EuBiologics Overview

  • Founded
  • 2010
Founded
  • Status
  • Public
  • Employees
  • 258
Employees
  • Stock Symbol
  • 206650
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $41.28
  • (As of Thursday Closing)

EuBiologics General Information

Description

EuBiologics Co Ltd is a biopharmaceutical company, which develops and supplies vaccines for epidemics and antibiotic resistance in South Korea. It offers Euvchol, an oral cholera prevention vaccine; and CRM197, a diphtheria toxin mutant vaccine, Inaba Cairo, and among others.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Stock Exchange
KRX
Primary Office
  • 8F Seongdo B/D 207 Dosan-daero
  • Sinsa-dong, Gangnam-gu
  • Seoul
  • South Korea
+82 00-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

EuBiologics Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$41.28 $40.66 $13.49 - $54.25 $1.45B 35.1M 1.06M -$2.48

EuBiologics Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 1,257,082 651,131 198,251 136,937
Revenue 28,537 24,130 28,362 22,647
EBITDA (68,496) (44,563) 2,226 2,879
Net Income (74,781) (50,931) (756) 3,440
Total Assets 137,110 142,958 80,084 61,019
Total Debt 18,141 20,690 24,082 17,249
Public Fundamental Data provided by Morningstar, Inc. disclaimer

EuBiologics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore EuBiologics‘s full profile, request access.

Request a free trial

EuBiologics Executive Team (4)

Name Title Board Seat Contact Info
Seuk-Keun Choi Ph.D Co-Chief Executive Officer
Yeong-Ok Baik Ph.D Co-Chief Executive Officer
Young-Shin Park Chief Quality Officer
You’re viewing 3 of 4 executive team members. Get the full list »

EuBiologics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EuBiologics Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 25-Feb-2021 00000 00000 00 0000 Drug Discovery
0000000 0000000 00 12-Jun-2020 00000 0000000 Biotechnology
ATGC (korea) 01-Jan-2019 Later Stage VC 00.000 Drug Discovery
To view EuBiologics’s complete investments history, request access »